Pioneering Partnerships

We know that finding the right partner makes everything possible. Today, approximately 50% of Genentech’s pipeline and marketed products derive from successful collaborations with companies and institutions from around the world.

Our Partnering team is passionate about creating value for everyone involved – people living with serious diseases, our partners, and the company as a whole.

  • 50% Portfolio derive from successful collaborations
  • ~60 Ongoing collaborations around the world
  • 90% Deals in pre-clinical setting

More than 40 years ago, Genentech was born out of a partnership – a collaboration between our co-founder Herb Boyer and his research colleague, Stanley Cohen, which led to the scientific breakthrough of engineering recombinant human DNA into bacteria. That collaboration laid the foundation for Genentech and the entire biotechnology industry.

Developing partnerships with companies and institutions around the globe that share our passion for advancing science has been one of our key strategies for success. Genentech and Roche combined their operations in 2009, and since then, our research and early development group has continued to embrace the spirit of a start-up, operating as an independent R&D center located in California.

To learn more about the most important factors a company should consider when looking for a partner, watch the video below.